Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure

Shirin Attarian; Chunli Yu; Karl E Anderson; Ellen W Friedman

doi:10.1182/bloodadvances.2017005660

Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure

Blood Adv. 2017 Jun 5;1(14):915-917. doi: 10.1182/bloodadvances.2017005660. eCollection 2017 Jun 13.

Authors

Shirin Attarian¹, Chunli Yu², Karl E Anderson^{3

4}, Ellen W Friedman¹

Affiliations

¹ Division of Hematology/Oncology, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.
² Department of Genetics and Genomic Sciences, The Icahn School of Medicine at Mount Sinai, New York, NY; and.
³ Division of Gastroenterology and Hepatology, Department of Internal Medicine, and.
⁴ Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, TX.

Abstract

Hemin and hemodialysis had an additive effect in decreasing ALA and PBG in our patient with acute intermittent porphyria and renal failure.The time course of ALA and PBG reaccumulation after hemodialysis is not known.